Quick answers
- What is Cupric chloride used for?
- The FDA-approved label (Copper, Hospira, Inc., May 18, 2026) says: “Copper (Cupric Chloride Injection) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Cupric chloride have a boxed warning?
- No. None of the 8 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Cupric chloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Cupric chloride been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Cupric chloride?
- 7 companies list prescription products of Cupric chloride in the FDA NDC Directory, including Archis Pharma LLC, Renova Pharmaceuticals LLC and Exela Pharma Sciences, LLC.
What Cupric chloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Copper (Cupric Chloride Injection) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
— FDA label: Copper, Hospira, Inc., effective May 18, 2026. Read the full label on DailyMed →
The FDA has 8 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 8 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution · Injection |
|---|---|
| Route | Intravenous |
| Prescription products | 7 in the FDA NDC Directory |
| Brand names | Copper |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Archis Pharma LLC2 products
- Renova Pharmaceuticals LLC1 product
- Exela Pharma Sciences, LLC1 product
- Somerset Therapeutics, LLC1 product
- Hospira, Inc.1 product
- Amneal Pharmaceuticals Private Limited1 product
- NorthStar Rx LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018960 CUPRIC CHLORIDE IN PLASTIC CONTAINER | Hospira | June 26, 1986 | 13, latest July 9, 2025 2025: Labeling · 2014: Manufacturing (CMC) · 2003: Labeling |
Generic approvals (4)
- ANDA212071Exela Pharma · October 31, 2022
- ANDA216113Somerset · April 30, 2024
- ANDA217626Stira · April 30, 2024
- ANDA217287Amneal · January 26, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 204536 |
|---|---|
| SPL set ID of the quoted label | a84d61a4-8e7f-4be1-aba6-f633b334aafc |
| FDA labels (SPL) | 8 |
| FDA applications | NDA018960, 4 ANDA |
| Active ingredients (FDA) | CUPRIC CHLORIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Copper, Hospira, Inc., effective May 18, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →